ChromaDex reports total revenues of $1.8 million for 1st quarter 2012 ChromaDex Corporation an innovative natural products organization that provides proprietary, science-based elements and solutions to the dietary supplement, food & beverage, aesthetic and pharmaceutical industries, announced its financial outcomes for the first quarter of 2012 today. ChromaDex announced total revenues, prepared relative to USA Generally Accepted Accounting Concepts , of around $1.8 million and a net loss attributable to common stockholders of $0.05 per share for the three-month period ended March 31, 2012.The anabolic steroids found in Anabolic Steroids WEB STORE help to perk up the ability of body to use proteins in addition to make muscles. The anabolic steroids for example testosterone help in building muscle and in addition dishearten the fats buildup. They could block the cortisol binding to the receptor sites that would evade muscle breakdown furthermore to also enhance recovery. Related StoriesFlu vaccine considerably reduces stroke riskHigh dosage flu vaccines significantly decrease hospitalization risk during influenza seasonGet your flu shot before fall festivities, says Loyola infectious disease specialistAccording to BMJ Information, Fineberg told users of WHO’s governing plank that the survey will deal with all of the criticisms levelled at the company, such as for example how it described a pandemic, and identify lessons for strengthening scope and preparedness for another response to a pandemic.